Jacobs Levy Equity Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-105,588
Closed -$2.92M 1062
2023
Q1
$2.92M Sell
105,588
-45,422
-30% -$1.2M 0.02% 499
2022
Q4
$3.43M Sell
151,010
-29,078
-16% -$809K 0.02% 459
2022
Q3
$6.13M Buy
+180,088
New +$6.66M 0.05% 349

Other funds holding PRVA

Jacobs Levy Equity Management's PRVA Position: Q2 2023 in Review

Jacobs Levy Equity Management sold out of Privia Health (PRVA) in Q2 2023, closing a stake of 105,588 shares — an estimated $2.92M sold.

Jacobs Levy Equity Management first reported a position in PRVA in Q3 2022 and held it in 3 quarters. The position peaked at $6.13M in Q3 2022. 234 funds tracked by Wall St. Rank hold PRVA as of Q2 2023.

  • Jacobs Levy Equity Management reported no remaining Privia Health position as of Q2 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 105,588 Privia Health shares in Q2 2023, an estimated $2.92M.
  • Jacobs Levy Equity Management first reported a position in Privia Health in Q3 2022 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Privia Health position peaked at $6.13M in Q3 2022.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q2 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.